Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine or Fentanyl for Refractory Dyspnea in COPD
2018-002466-39Phase 4Active
- Sponsor
- University Medical Center Groningen
- Start
- Nov 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Morphine, Fentanyl patch and Placebo (3 arms). Primary endpoint: Change in dyspnea sensation. Started Nov 2018; status: active.
02
Drugs
morphinefentanyl
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2018-002466-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002466-39.